Research Output per year
Fingerprint Dive into the research topics where Olaf-Georg Issinger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Casein Kinase II
Medicine & Life Sciences
Holoenzymes
Medicine & Life Sciences
Phosphorylation
Chemical Compounds
Catalytic Domain
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Enzymes
Medicine & Life Sciences
Protein Kinases
Chemical Compounds
Cells
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1972 2019
Delivery of proteins encapsulated in chitosan-tripolyphosphate nanoparticles to human skin melanoma cells
Stie, M. B., Thoke, H. S., Issinger, O-G., Hochscherf, J., Guerra, B. & Olsen, L. F., Feb 2019, In : Colloids and Surfaces B: Biointerfaces. 174, p. 216-223Research output: Contribution to journal › Journal article › Research › peer-review
Chitosan
Bovine Serum Albumin
Melanoma
delivery
Skin
Natural compounds and derivatives as Ser/Thr protein kinase modulators and inhibitors
Guerra, B. & Issinger, O-G., 2019, In : Pharmaceuticals. 12, 1, 21 p., 4.Research output: Contribution to journal › Review › Research › peer-review
Open Access
File
Protein Kinase Inhibitors
Phosphoprotein Phosphatases
Enzymes
Pharmaceutical Preparations
Neoplasms
Nuclear localization of the CK2α-subunit correlates with poor prognosis in Clear Cell Renal Cell Carcinoma
Rabjerg, M., Guerra, B., Oliván-Viguera, A., Mikkelsen, M. L. N., Köhler, R., Issinger, O. G. & Marcussen, N., 3. Jan 2017, In : Oncotarget. 8, 1, p. 1613-1627Research output: Contribution to journal › Journal article › Research › peer-review
Open Access
File
Casein Kinase II
Neoplasms
Oxyphilic Adenoma
Nuclear Proteins
Disease-Free Survival
Acetoxymethyl ester of tetrabromobenzimidazole-peptoid conjugate for inhibition of protein kinase CK2 in living cells
Viht, K., Saaver, S., Vahter, J., Enkvist, E., Lavogina, D., Sinijarv, H., Raidaru, G., Guerra, B., Issinger, O-G. & Uri, A., 2015, In : Bioconjugate Chemistry. 26, 12, p. 2324-2335Research output: Contribution to journal › Journal article › Research › peer-review
A note of caution on the role of halogen bonds for protein kinase/inhibitor recognition suggested by high- and low-salt CK2α complex structures
Guerra, B., Bischoff, N., Bdzhola, V., Yarmoluk, S. M., Issinger, O-G., Golup, A. & Niefind, K., 2015, In : A C S Chemical Biology. 10, 7, p. 1654-1660Research output: Contribution to journal › Journal article › Research › peer-review
Activities 2007 2019
Drug Discovery 2019
Olaf-Georg Issinger (Participant)5. Nov 2019 → 6. Nov 2019
Activity: Attending an event › Conference organisation or participation
Pharmaceuticals (Journal)
Olaf-Georg Issinger (Editor)17. Feb 2019
Activity: Editorial work and peer review › Editor of research journal › Research
ELRIG 2018 - Drug Discovery for Small & Large Molecules
Olaf-Georg Issinger (Participant)9. Oct 2018 → 10. Oct 2018
Activity: Attending an event › Organisation or participation in workshops, courses or seminars
Drug Discovery
Olaf-Georg Issinger (Participant)3. Oct 2017 → 4. Oct 2017
Activity: Attending an event › Organisation or participation in workshops, courses or seminars
Frontiers (Journal)
Olaf-Georg Issinger (Editor)31. Jul 2014
Activity: Editorial work and peer review › Editor of research journal › Research
Projects 2006 2015
- 7 Finished
Uddannelses- og Forskningsministeriet - FNU - Protein kinases CK2 and Chk2: Elucidatating thir biochemical and cellular mode of activation.
01/01/2008 → 31/12/2008
Project: Research
Kræftens Bekæmpelse - betydningen af enzymet AMPK og dets indflydelse udvikling af tumorer i nyrene.
01/02/2009 → 30/06/2009
Project: Research
Uddannelses- og Forskningsministeriet - FNU - CK2 and AMPK: Exploration and interference with their activation status
01/01/2011 → 30/06/2014
Project: Research